Study Evaluating Effects of Multiple-Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non-Obese and Obese Postmenopausal Women
| Status: | Completed |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 40 - 64 |
| Updated: | 5/5/2014 |
| Start Date: | April 2014 |
| End Date: | August 2014 |
| Contact: | Pfizer CT.gov Call Center |
| Phone: | 1-800-718-1021 |
A Phase 1, Open Label, Two Period, Fixed Sequence, Parallel Group Study to Estimate the Effects of Multiple Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non Obese (BMI <30 Kg/m2) and Obese (BMI ≥30 Kg/m2) Postmenopausal Women
This study will assess if itraconazole will affect the blood levels of Duavee when they are
given together. This study will also assess if a subject's body size affects the blood
levels of Duavee.
given together. This study will also assess if a subject's body size affects the blood
levels of Duavee.
Inclusion Criteria:
- Generally healthy postmenopausal women, aged 40-64. Intact Uterus
Exclusion Criteria:
- The use of oral, vaginal, or transdermal estrogen, androgen or progestin-containing
medications within 30 days before study drug administration.
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials